Authors


Richard O. Davis, PhD

Latest:

No Time to Waste: Decreasing Patient Wait Times for Chemotherapy Administration Using Automated Prioritization in an Oncology Pharmacy System

Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.


Rebecca Killion, MA

Latest:

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.


Ruslana Tsurikova, MA

Latest:

Effects of Documentation-Based Decision Support on Chronic Disease Management

A trial of electronic note–based decision support showed small effects on management of patients with heart disease and diabetes, mostly because it was infrequently used.


Jonathan Lim, MSc

Latest:

Initiation of Triple Therapy Maintenance Treatment Among Patients With COPD

Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.


Tomorrow’s Multiple Myeloma Treatments

Latest:

Initial Success, Frequent Recurrence

Interview with David Siegel, MD, chief of the Division of Multiple Myeloma, John Theurer Cancer Center





Robert Sweetman, MD

Latest:

Molecular Testing Patterns in Metastatic Non—Small Cell Lung Cancer

Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.



Norma B. Coe, PhD

Latest:

Insurance Coverage and Health Care Spending by State-Level Medigap Regulations

Despite their intention to protect against coverage denial and/or premium increases, additional state-level Medigap regulations are correlated with lower Medigap enrollment and stronger moral hazard.



Miriam Kuppermann, PhD, MPH

Latest:

Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome

This cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.


Cherie Peterson, RN, MS

Latest:

Review of Veterans Health Administration Telemedicine Interventions

A review of exemplary VHA-sponsored telemedicine interventions indicates that telemedicine can efficiently address patient healthcare needs.



Jane Null Kogan, PhD

Latest:

Delivering on the Value Proposition of Precision Medicine: The View From Healthcare Payers

Genomics-based precision medicine has the potential to transform healthcare delivery. However, effective collaborations among scientists, clinicians, and payers are needed to accelerate the translation of precision medicine to clinical practice and ensure its sustainability.


Ronald J. Halbert, MPH, MD

Latest:

US Payer Perspectives on Evidence for Formulary Decision Making

To improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.




Amy Davidoff, PhD

Latest:

Medication Adherence and Medicare Expenditure Among Beneficiaries With Heart Failure

Modest increases in adherence to medication regimens among Medicare patients with heart failure were associated with lower Medicare spending in 3 major drug classes.



Woodson Merrell, MD

Latest:

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.





Kenneth R. Carson, MD

Latest:

Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib

Ibrutinib has been selected for Medicare price negotiation under the Inflation Reduction Act. The authors summarize the House Oversight Committee investigation to be considered by CMS during the price negotiation process.



Craig T. Cheetham, PharmD, MS

Latest:

Impact of MMRV Combination Vaccine on Childhood Vaccination Compliance

Although vaccination compliance increased slightly following use of combination MMRV instead of separate MMR and varicella vaccines, additional barriers to improved compliance warrant future evaluation.


Toni Ann Seay, MPH, MA

Latest:

Hepatitis C Care Cascade Among Persons Born 1945-1965: 3 Medical Centers

In this analysis of patients with newly diagnosed hepatitis C, linkage to care was largely successful in the 1945-1965 birth cohort, but treatment initiation remained low. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.


Aaron R. Wells, PhD

Latest:

Impact of a Scalable Care Transitions Program for Readmission Avoidance

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo